VIVAN Life Sciences Blog
Rs 2,277 drug can treat hepatitis B patients
An effective drug for treating hepatitis B virus (HBV) could be mass-produced for as little as USD 36 per person per year against the current US price of over USD 15,000, scientists say.
The advance could lead to huge reductions in the number of people being infected with Hepatitis B which causes liver cancer and liver cirrhosis, both of which can be fatal.
Researchers from the University of Liverpool analysed the factors which influence the cost of manufacturing of drugs for H ..
